A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function

Clinical trial NCT05469100 · COMPLETED

Trial details

NCT number: NCT05469100
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Renal Insufficiency

Start date: 2018-12-19
Primary completion: 2019-08-07
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.